Extensions

Patent Term and Family Details for U.S. Patent 8,549,339

Projected Expiration Date: August 4, 2031

Based on a review of the United States Patent and Trademark Office (USPTO) records, U.S. Patent No. 8,549,339 has a projected expiration date of August 4, 2031. This date includes a Patent Term Adjustment (PTA).

The patent was filed on February 26, 2010, and granted on October 1, 2013. Without any adjustments, its term would typically end 20 years from the filing date, in February 2030. However, the USPTO has granted a PTA, extending the patent's life.

Continuity and Family Data:

U.S. Patent 8,549,339, which issued from application number 12/713,220, does not have any domestic parent or child applications, such as continuations or divisionals, in the United States.

However, the patent is part of a larger international patent family. The original U.S. application serves as the priority document for several foreign counterparts. These include:

• World Intellectual Property Organization (WIPO): WO2011106172A1
• China: CN102667744B
• Japan: JP5547820B2
• South Korea: KR101426341B1
• Germany: DE112011100695T5

The legal status of these international family members varies, with several listed as expired due to non-payment of fees or having been withdrawn.

There are no recorded Patent Term Extensions (PTE) for this patent under 35 U.S.C. § 156, which are typically granted for delays in regulatory review for products such as pharmaceuticals.